0.00Open0.20Pre Close0 Volume51 Open Interest10.00Strike Price0.00Turnover0.00%IV232.03%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier-9DDays to Expiry0.20Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma15.36Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Kazia Therapeutics Stock Discussion
Kazia Therapeutics to Present Data Highlighting Synergistic Activity Between Paxalisib and Immunotherapy in Immunotherapy-Resistant Triple Negative Breast Cancer Model at the San Antonio Breast Cancer Symposium
Wednesday, 11th December at 8:00 am
SYDNEY, Dec. 11, 2024 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA), an oncology-focused drug development, announced that data from two abstracts will be presented at the San Antonio Breast Cancer Symposium ...
📊⚡️📊
Larger Image: tradingview.com...
$Kazia Therapeutics (KZIA.US)$
📊⚡️📊
📊⚡️📊
No comment yet